# Engineering a Glucose-Responsive Glucagon Prodrug Through Arginine-Phenylboronic Acid Pendant Modification.

> PubMed lists PMID 41810046 in Small science as Journal Article, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41810046-glucagon:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-13
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41810046-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41810046-glucagon-v1.json
- Content SHA-256: `257644c92385bb20f1d91c2499a36c0f43be50a5296d12952f9949211ef83511`

## Claims and source pins

### Headline

Engineering a Glucose-Responsive Glucagon Prodrug Through Arginine-Phenylboronic Acid Pendant Modification. ([`pubmed-observation-pmid-41810046-2026-08-13-13fdb21acb92`](#source-pubmed-observation-pmid-41810046-2026-08-13-13fdb21acb92))

### Summary

PubMed lists PMID 41810046 in Small science as Journal Article, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41810046-2026-08-13-13fdb21acb92`](#source-pubmed-observation-pmid-41810046-2026-08-13-13fdb21acb92))

### Paragraph 1

PubMed lists PMID 41810046 in Small science as Journal Article, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41810046-2026-08-13-13fdb21acb92`](#source-pubmed-observation-pmid-41810046-2026-08-13-13fdb21acb92))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41810046-2026-08-13-13fdb21acb92`](#source-pubmed-observation-pmid-41810046-2026-08-13-13fdb21acb92))

## Sources

<a id="source-pubmed-observation-pmid-41810046-2026-08-13-13fdb21acb92"></a>
- **Engineering a Glucose-Responsive Glucagon Prodrug Through Arginine-Phenylboronic Acid Pendant Modification. · retained source version 1:2026-08-13:current:13fdb21acb9236712917720dec562a0e909a8be568a09d8cd6b2f1f587a9bb26** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41810046/) (`pubmed-observation-pmid-41810046-2026-08-13-13fdb21acb92`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Engineering a Glucose-Responsive Glucagon Prodrug Through Arginine-Phenylboronic Acid Pendant Modification." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41810046-glucagon-v1.json SHA-256: 257644c92385bb20f1d91c2499a36c0f43be50a5296d12952f9949211ef83511.